OraSure Corp (OSUR) - Kewajiban jangka dawa marang modal

OraSure Corp - logo grafis emiten OSUR

The stability of OraSure Technologies (OSUR) is underpinned by patents for rapid tests and close ties to the public healthcare sector. Demand for genetic research remains largely independent of economic crises, although sales of consumables may fluctuate. This price chart, where the indicator stands at 0.05, reflects the dynamics of a leader in the development of mobile software and next-generation molecular diagnostic systems.

OraSure - Utang jangka dawa marang modal OSUR (periode 04.07.2022 - 29.10.2026)
Sampel barang OraSure Technologies

OraSure Technologies investments in the democratization of home diagnostics require a balance between capital expenditures and debt load, which is reflected in the dynamics of long-term loans to equity. This indicator compares obligations with a maturity of more than one year against net assets, allowing for an assessment of the degree of financial leverage and the stability of the capital structure while scaling innovative DNA collection systems.

Perusahaan pesaing

Rasio utang jangka dawa marang ekuitas Agilent Technologies, Inc. (A)|Utang jangka dawa marang modal DGX|ILMN - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal EXAS (Exact Sciences)|RVTY: Rasio utang jangka dawa marang modal|Bio-Rad - Utang jangka dawa marang modal|NNNN - Utang jangka dawa marang modal|Sterigenics (SHC) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal QDEL|OPK (OPKO Health, Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal CareDx Corp|Utang jangka dawa marang ekuitas Maravai LifeSciences Holdings, Inc. (MRVI)|Utang jangka dawa marang ekuitas FLGT (Fulgent Genetics Inc)|Fluidigm - Rasio utang jangka dawa marang ekuitas|Cytek Corp (CTKB) - Kewajiban jangka dawa marang modal|XGN - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal mdxhealth.com MDXH|LUCD: Utang jangka dawa marang modal|PRE - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ProPhase Labs, Inc. (PRPH)|AIMD - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Co-Diagnostics CODX|Koefisien utang jangka dawa marang modal HSCS|Biomerica, Inc - Utang jangka dawa marang modal|CDIO - Utang jangka dawa marang modal|Virax Biolabs Group (VRAX) - Utang jangka dawa marang ekuitas|BJDX - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas AWH|Utang jangka dawa marang modal Accelerate Diagnostics Inc.|Utang jangka dawa marang ekuitas CENTOGENE, N.V. (CNTG)|ENZ (enzo.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal FRES (Fresh2 Group)|Genetic Technologies Ltd (GENE) - Kewajiban jangka dawa marang modal|ME: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PMD (Psychemedics Corp.)